✦ LIBER ✦

Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy

✍ Scribed by Koichi Azuma; Yoshihiro Komohara; Tetsuro Sasada; Yasuhiro Terazaki; Jiro Ikeda; Tomoaki Hoshino; Kyogo Itoh; Akira Yamada; Hisamichi Aizawa

Book ID: 108583966
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 636 KB
Volume: 98
Category: Article
ISSN: 1347-9032
DOI: 10.1111/j.1349-7006.2007.00557.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disease-free survival of patients after

Disease-free survival of patients after surgical resection of non-small cell lung carcinoma and correlation with excision repair cross-complementation group 1 expression and genotype

✍ MANALJAV TSEDEN-ISH; YOO-DUK CHOI; HYUN-JU CHO; HEE-JUNG BAN; IN-JAE OH; KYU-SIK 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 845 KB

Protein expression levels of excision re

Protein expression levels of excision repair cross-complementation group 1 and xeroderma pigmentosum D correlate with response to platinum-based chemotherapy in the patients with advanced epithelial ovarian cancer

✍ K. LIN; D. YE; X. XIE 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

RRM1gene expression in peripheral blood

RRM1gene expression in peripheral blood is predictive of shorter survival in Chinese patients with advanced non-small-cell lung cancer treated by gemcitabine and platinum

✍ Lin-run Wang; Guo-bing Zhang; Jian Chen; Jun Li; Ming-wei Li; Nong Xu; Yang Wang 📂 Article 📅 2011 🏛 SP Zhejiang University Press 🌐 English ⚖ 483 KB

Predictive value of ERCC1 and XPD polymo

Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis

✍ Shu-zhen Wei; Ping Zhan; Mei-qi Shi; Yi Shi; Qian Qian; Li-ke Yu; Yong Song 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 338 KB

Impact of angiotensin I converting enzym

Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy

✍ Stefan Wilop; Sabine von Hobe; Martina Crysandt; Albert Esser; Rainhardt Osieka; 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 319 KB